PATENT CLAIM ANALYSIS

Application Number: 16130860
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "045000"]

Abstract:
Buccal aerosol sprays or capsules using polar and non-polar solvents have now been developed which provide zolpidem for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention comprise formulation I: aqueous polar solvent, zolpidem, and optional flavoring agent; formulation II: aqueous polar solvent, zolpidem, optionally flavoring agent, and propellant; formulation III: non-polar solvent, zolpidem, and optional flavoring agent; formulation IV: non-polar solvent, zolpidem, optional flavoring agent, and propellant; formulation V: a mixture of a polar solvent and a non-polar solvent, zolpidem, and optional flavoring agent; formulation VI: a mixture of a polar solvent and a non-polar solvent, zolpidem, optional flavoring agent, and propellant.

Claim (Index 63):
An oral spray composition comprising\n zolpidem tartarate in an amount of about 4-5% by weight of the total composition, propylene glycol in an amount about 30-40% by weight of the total composition, and a flavoring agent at in an amount about 0.1-0.3% by weight of the total composition.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 2.58182
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10671715', '12576457', '10726585', '10726625', '13445331']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7971766727297236
- 35 USC 102 Novelty (BERT): 0.5533344969027486
- Combined Prediction Score: 0.7727924551470261
- Mean Citation Score: 406.250648
- Max Citation Score: 449.71216
- Similarity Product: 328.08273685112005

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test